People interested in using contraception continue to face barriers to access. Strategies such as over-the-counter (OTC) access, telehealth provision, and pharmacist prescribing may help to reduce these barriers for some people, especially when services are available at an accessible price or covered by insurance. The US Food and Drug Administration’s approval of Opill (norgestrel 75 mcg) as the first daily oral contraceptive for over-the-counter sale is an important precedent that may lead to the approval of other OTC hormonal contraceptives. Until all hormonal methods are available without a prescription, other strategies may help to improve access to these contraceptive methods.